Effects of sodium-glucose co-transporter 2 inhibitors on liver parameters and steatosis: A meta-analysis of randomized clinical trials.
Francisca Dos Santos CoelhoMarta Borges-CanhaMadalena von HafeJoão Sérgio NevesCatarina ValeAna Rita LeiteDavide CarvalhoAdelino Leite-MoreiraPublished in: Diabetes/metabolism research and reviews (2020)
Treatment with SGLT2 inhibitors improves liver structure and function in patients with T2D. This meta-analysis suggests that SGLT2 inhibitors are a promising pharmacological approach for treatment of NAFLD.